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Abstract 
We present a case of a 40-year-old female
from Turkey, who was referred to our outpa-
tient clinic for an undetermined thalassemia
and sickle cell trait. At first consultation hemo-
globin was decreased (71 g/L) with microcyto-
sis (MCV 55.1 fL), and hypochromia (MCHC
239 g/L). The patient had severe iron deficien-
cy. Brilliant cresyl blue staining showed >50%
of the erythrocytes with typical Hemoglobin H
(HbH)  inclusions.  High-performance  liquid
chromatography (HPLC) revealed normal lev-
els of HbA2 and Hemoglobin F (HbF), and addi-
tionally a hemoglobin S (19%). Molecular diag-
nostics revealed the mutations α2 IVS-I donor
site -5nt and a -- MED II deletion in the alpha
gene complex and confirmed the heterozygote
mutation  of  the  beta-gene  at  codon  6
(HBB:c.20A>T; HbS). In conclusion, we pres-
ent an extremely rare combination of HbH dis-
ease  and  sickle  cell  trait.  This  combination
may explain the mild form of the HbH disease,
with moderate anemia, splenomegaly but iron
deficiency, rather than iron overload, as usual-
ly observed in HbH disease. 
Introduction 
α-Thalassemia is a common genetic disor-
der that is characterized by deficient or absent
synthesis of α-globin chains of the hemoglobin
(Hb)  molecule.1 The  human  α-globin  gene
cluster has two α genes (α2 and α1) on each
chromosome  16.  A  normal  person  has  four
functional α-globin genes and is designated as
αα/αα.2 Most  α-thalassemia  determinants
are deletions involving one ( −α/αα) or both:
loss of either both α-genes from a single chro-
mosome ( - - /αα) or one gene from both chro-
mosomes ( - α/ - α). An individual with three
α genes (−α/αα) is not anemic but a het-
erozygote who inherits two functional α-globin
genes (– –/αα) has mild hypochromic micro-
cytic anemia. Patients with HbH disease inher-
it only one functional α-globin gene (– –/−α).
They usually produce less than 30% of the nor-
mal amount of α-globin. The patients usually
have splenomegaly (which may be severe) and
occasionally  this  is  complicated  by  hyper-
splenism.1,3
Sickle-cell  anemia  is  an  autosomal  reces-
sive genetic red cell disorder with a worldwide
distribution that results from a point mutation
at codon 6 of the beta-globin gene, with the
replacement of glutamic acid to valine, leading
to  the  production  of  a  defective  beta  globin
chain (βS, 6V) of the hemoglobin.4 While the
coinheritance  of  another  beta-globin  gene
anomaly increases the proportion of HbS and
therefore the risk of sickling, the combination
of a deletion of an alpha-gene anomaly reduces
intraerythrocytic HbS concentration, attenuat-
ing therefore the problems due to the sickle
cell trait.5 Since sickle cell trait is mainly seen
in black populations, the coinheritance of HbH
disease and a sickle cell trait has only been
rarely described. 
Usually, in patients with HbH disease, inef-
fective erythropoiesis in an expanded marrow
stimulates iron absorption even if iron stores
are adequate, and this stimulation increases
the risk of iron excess when transfusions are
given.6 We show here a rare case of a coinher-
itance of a HbH disease together with a sickle
cell trait, presenting with iron deficiency.
Case Report
A 40-year-old Turkish woman was referred to
our outpatient clinic for evaluation and treat-
ment  of  an  undetermined  thalassemia  and
sickle  cell  trait.  The  patient  suffered  from
fatigue  and  splenomegaly.  Additionally,  she
had hepatitis B virus infection most probably
transfusion transmitted. The patient has two
healthy children. 
At first consultation hemoglobin (Hb) was
decreased  (71  g/L)  with  microcytosis  (MCV
55.1 fL), hypochromia (MCHC 239 g/L), aniso-
cytosis (RDW 20.5 %) and hypochromic reticu-
locytes (CHr 16.2 pG) (Table 1). Leucocyte and
platelet counts were within the normal range.
On  the  blood  smear  we  found  anisocytosis,
poikilocytosis,  anisochromia,  microcytes  and
target cells. The patient had severe iron defi-
ciency (ferritin level 7 ng/mL; transferrin satu-
ration  7%).  In  brilliant  cresyl  blue  staining
more than 50% of the erythrocytes showed typ-
ical HbH inclusions. The sickle cell test was
positive. HPLC (High-performance liquid chro-
matography) revealed a normal HbA2 (2.3%)
and HbF (0.7%), an abnormal hemoglobin S
(19%) and persistence of HbA (>50%) (Table 2
and  Figure  1).  Genomic  DNA  was  isolated
using manual or automated extraction proto-
cols. Using a reverse-hybridization of biotiny-
lated  PCR  products  (ViennaLab)  a  heterozy-
gous  mutation  of  the  β gene  at  codon  6
(HBB:c.20A>T;  corresponding  to  HbS),  was
detected. The α-globin genes were amplified
by  PCR  and  sequenced  using  the  BigDye™
Terminator Cycle Sequencing Kit, and the ABI
3130 automated capillary sequencer (Applied
Biosystems  Inc.,  Foster  City,  CA,  USA).  We
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Figure  1.  High-performance  liquid  chro-
matography  pattern  of  our  patient  with
Hemoglobin H (HbH) disease. Red graph
represents  our  patient  with  clear
HbH/HbBart’s peak at 1.5 minutes and a
HbS  peak  at  11  minutes  retention  time.
Blue graph is a control.[Hematology Reports 2011; 3:e30]
revealed a 5 nucleotide deletion in the IVS-I
donor  site  (GAGGTGAGG>GAGG-----)  of  the
α2-globin gene (Figure 2). This deletion was
pseudo-homozygote since we showed later that
one allele of the alpha gene complex contained
a 6.1kb deletion eliminating both alpha genes.
Multiplex  Ligation-dependent  Probe  Amplifi  -
cation (MLPA) reactions were performed for
detection of copy number variation in the α-
globin  gene  clusters.  The  reaction  was  per-
formed according to the manufacturers proto-
col using the SALSA MLPA kit P140B2 HBA and
the ServiceXS HBA kit described by Harteveld
et al., 2005.7 Products were separated by capil-
lary electrophoresis on the ABI 3130 (Applied
Biosystems)  and  data  analysed  using
GeneMarker (SoftGenetics). Threshold ratios
for deletion and duplication were set at >0.75
and >1.3, respectively. We found a heterozy-
gous deletion of probes 5-25 with the P140B2
kit and of probes 8-15 with the ServiceXS kit.
This corresponds to a more than 6.1kb long
deletion of one allele in the alpha gene com-
plex including the zeta and both alpha genes,
leaving the theta gene intact. This type of dele-
tion is called - - Med-II and is rather common
in the Mediterranean area and was frequently
found in the Turkish/Greek population.8
Thus this patient suffers from HbH disease
and a sickle cell trait; the HbH disease was due
to  an  α0-thalassemia  (-  -Med-II)  /  α+-tha-
lassemia (α2 IVS-I donor site -5nt). The symp-
tomatic anemia with iron deficiency was treat-
ed with iron infusion with a total dose of 1500
mg ferric carboxy-maltose. Thereafter, the Hb
levels increased up to 83 g/L, the ferritin level
to 33 ʼg/L and the transferrin saturation to
14% (Table 1). 
Discussion
We show here a patient with a rare heredi-
tary  constellation  of  three  different  genetic
anomalies  of  the  haemoglobin  genes:  the
patients presented HbH disease with two dele-
tions  on  the  alpha  genes  and  a  sickle  cell
anomaly on the beta gene. The coinheritance
of HbH and sickle cell trait is rare.9 There are
only few published case reports about the coin-
cidence of HbH disease with a -- MED II dele-
tion and a Hb S heterozygosity.10-11 
HbH  disease  is  a  severe  form  of  α-tha-
lassemia but is compatible with life. Patients
with HbH disease have a severe hypochromia
with low MCV and MCH values, but increased
iron stores.
In  our  case,  the  moderate,  microcytic
hyochromic  anemia  and  the  splenomegaly
were  the  consequences  of  the  HbH  disease,
and could not be reversed by iron substitution.
However, we assume that the structural beta-
globin  chain  variant  in  our  patient  leads  to
lower quantities of unstable HbH, and there-
fore to a milder form of HbH disease with less
ineffective  hematopoiesis  and  only  minimal
increase  of  gastrointestinal  iron  absorption.
Hypermenorrhoea and two pregnancies were
additional reasons for the unusual iron defi-
ciency in this case of thalassemia.
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Table 1. Hematological data from the patient.
Parameter,  At 1st presentation 3 months after   Reference 
Units 1500 mg values
Ferric carboxy-maltose 
infusion
Hb, g/L 71 83 120-160
HCT,  L/L 0.30 0.33 0.36-0.46
MCV, fL 55.1 55.1 79-95
MCH, pG 13.2 13.7 27.0-33.2
MCHC, g/L 239 250 320-360
hypoRBC, % 76.1 69.8 <5.0
RDW, % 20.5 19.9 11.5-14.5
Platelets, ﾥ109/L 214 162 150-450
Reticulocytes, ‰ 20 22 10-27
Reticulocytes, x109/L 108 112 40-140
WBC, ﾥ109/L 4.85 6.02 3.50-10.00
Neutrophils, ﾥ109/L 3.42 4.38 1.300-6.700
Ferritin, ng/mL 7 33 10-200
Transferrin saturation, % 7 14 16-45%
sTR, mg/L 23.11 11.64 2.2-4.5
Hb, hemoglobin; HCT, hematocrit; MCV, mean corpuscolar volume; MCHC, mean corpuscolar hemoglobin concentration; RDW, red cell distri-
bution width; hypoRBC, hypochromic erythrocyte; sTR, soluble transferrin receptor; WBC, white blood cells.
Table 2. Quantitave values of hemoglobin components from the patient obtained by
High-performance liquid chromatography and results of molecular analysis.
Parameter Value References
Hb A2, % 2.3 2.0-3.5
Hb F,% 0.7 <2
Hb H, % 11 0
Abnormal Hb HbS None
Perc. abnormal Hb, % 19 0
Sickle cell test Positive Negative
Mutation analysis 1.α2 IVS-I donor site -5nt / -- MED II deletion
2. heterozygous Hb S (HBB:c.20A>T)
Hb, hemoglobin.
Figure 2. Sequence of the alpha 2 gene. Hemizygote deletion of 5 nucleotides at the IVS-
I donorsite of the alpha2 gene, HBA2:c.95+2_95+6delTGAGG.[page 100] [Hematology Reports 2011; 3:e30]
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